Search

everythinglearnresearchcommunity

for

Search:↓

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

A reliable system was developed to distinguish hair growth stages, aiding in identifying hair growth promoters or inhibitors.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Sox9 is present in most canine skin tumors and may help understand stem cells' role in these cancers.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

New treatments for common hair loss are needed.

Meibomian glands are highly specialized and differ significantly from other sebaceous glands in structure and function.

Combining PRP with minoxidil significantly improves hair growth in AGA patients.

The review suggests that a special cell-derived treatment shows promise for various skin conditions and hair growth but needs more research for confirmation.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Platelet Rich Plasma-Derived Extracellular Vesicles show promise for healing and regeneration but need standardized methods for consistent results.

Different fibroblasts play key roles in skin healing and scarring.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Blue light therapy is safe for skin and may protect against UV radiation.

Cyclosporine A can help some people with severe alopecia areata regrow hair.

Topical PRP cream may improve facial skin by boosting collagen.

Platelet-Rich Plasma may improve skin health and reduce wrinkles, but more research is needed for standard treatment guidelines.

Minoxidil and finasteride are effective for treating hair loss, with dutasteride showing potential but with side effects.

The study found that specific proteins are markers of hair follicle development in human fetuses.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

Teen hair loss is common, can be caused by genetics or health issues, and can be diagnosed and treated.

Several treatments are effective for pigmentary disorders like vitiligo and melasma.

Melatonin improved secondary hair growth in goats but didn't affect primary hair density or litter size.

Early-stage male pattern baldness shows two types of hair loss: one on the top of the head linked to hormonal changes, and another at the back of the head. The top hair loss responds well to specific treatment, while the back hair loss does not.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Finasteride reduces hair follicle cell death in androgenetic alopecia.

Using your own skin cells can help repair aging skin and promote hair growth.

The document concludes that advanced methods show the presence of P. acnes in acne lesions but do not prove it causes acne.